PUBLICATION
Synthetic resin acid derivatives selectively open the hKV 7.2/7.3 channel and prevent epileptic seizures
- Authors
- Ottosson, N.E., Silverå Ejneby, M., Wu, X., Estrada-Mondragón, A., Nilsson, M., Karlsson, U., Schupp, M., Rognant, S., Jepps, T.A., Konradsson, P., Elinder, F.
- ID
- ZDB-PUB-210605-7
- Date
- 2021
- Source
- Epilepsia 62(7): 1744-1758 (Journal)
- Registered Authors
- Keywords
- epilepsy, excitability, potassium channel opener
- MeSH Terms
-
- Animals
- Anticonvulsants/pharmacology*
- Carbamates/pharmacology
- Epilepsy/prevention & control*
- Humans
- Ion Channel Gating/drug effects
- KCNQ2 Potassium Channel/drug effects*
- KCNQ3 Potassium Channel/drug effects*
- Larva
- Oocytes
- Patch-Clamp Techniques
- Phenylenediamines/pharmacology
- Resins, Synthetic/pharmacology*
- Seizures/prevention & control*
- Substrate Specificity
- Xenopus laevis
- Zebrafish
- PubMed
- 34085706 Full text @ Epilepsia
Citation
Ottosson, N.E., Silverå Ejneby, M., Wu, X., Estrada-Mondragón, A., Nilsson, M., Karlsson, U., Schupp, M., Rognant, S., Jepps, T.A., Konradsson, P., Elinder, F. (2021) Synthetic resin acid derivatives selectively open the hKV 7.2/7.3 channel and prevent epileptic seizures. Epilepsia. 62(7):1744-1758.
Abstract
Objective About one third of all patients with epilepsy have pharmacoresistant seizures. Thus there is a need for better pharmacological treatments. The human voltage-gated potassium (hKV ) channel hKV 7.2/7.3 is a validated antiseizure target for compounds that activate this channel. In a previous study we have shown that resin acid derivatives can activate the hKV 7.2/7.3 channel. In this study we investigated if these channel activators have the potential to be developed into a new type of antiseizure drug. Thus we examined their structure-activity relationships and the site of action on the hKV 7.2/7.3 channel, if they have unwanted cardiac and cardiovascular effects, and their potential antiseizure effect.
Methods Ion channels were expressed in Xenopus oocytes or mammalian cell lines and explored with two-electrode voltage-clamp or automated patch-clamp techniques. Unwanted vascular side effects were investigated with isometric tension recordings. Antiseizure activity was studied in an electrophysiological zebrafish-larvae model.
Results Fourteen resin acid derivatives were tested on hKV 7.2/7.3. The most efficient channel activators were halogenated and had a permanently negatively charged sulfonyl group. The compounds did not bind to the sites of other hKV 7.2/7.3 channel activators, retigabine, or ICA-069673. Instead, they interacted with the most extracellular gating charge of the S4 voltage-sensing helix, and the effects are consistent with an electrostatic mechanism. The compounds altered the voltage dependence of hKV 7.4, but in contrast to retigabine, there were no effects on the maximum conductance. Consistent with these data, the compounds had less smooth muscle-relaxing effect than retigabine. The compounds had almost no effect on the voltage dependence of hKV 11.1, hNaV 1.5, or hCaV 1.2, or on the amplitude of hKV 11.1. Finally, several resin acid derivatives had clear antiseizure effects in a zebrafish-larvae model.
Significance The described resin acid derivatives hold promise for new antiseizure medications, with reduced risk for adverse effects compared with retigabine.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping